Expression of the tumor suppressor retinoic acid receptor β2 (RARβ2), reduced in breast cancer [29], [30], and dependent on COUP-TFII [31] was increased by nucleolin overexpression. This evidence concerns the gene NR2F2 and breast carcinoma.